Latest News and Press Releases
Want to stay updated on the latest news?
-
NASHVILLE, Tenn., April 02, 2019 (GLOBE NEWSWIRE) -- Digital Reasoning, the global leader in trusted AI solutions for understanding human communications and behavior, announced today that Chris...
-
Tumor-selective CBX-11 allows full dose co-administration with chemotherapy, enabling synergistic efficacy in HRD negative tumors Poster presentation today during AACR Annual Meeting 2019 ...
-
WATERTOWN, Mass., April 02, 2019 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq: SELB) (“Selecta”), a clinical-stage biotechnology company focused on unlocking the full potential of biologic...
-
VANCOUVER, British Columbia, April 02, 2019 (GLOBE NEWSWIRE) -- ALORO MINING CORP. (the “Company” or “Aloro”) (TSX.V Symbol AORO) (FRANKFURT Symbol 4LPP) is pleased to announce that it has...
-
DUBAI, United Arab Emirates, April 02, 2019 (GLOBE NEWSWIRE) -- Sage (FTSE: SGE), the market leader for cloud business management solutions, today announced the release of Sage Business Cloud...
-
CAMBRIDGE, Mass., April 02, 2019 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is generating red blood cells and bioengineering them...
-
HENDERSON, Nev., April 02, 2019 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTC: UEEC) (“UHP” or the “Company”), manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the...
-
SAN JOSE, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- eSilicon, a leading provider of FinFET-class ASICs, market-specific IP platforms and advanced 2.5D packaging solutions, will demonstrate its 7nm...
-
BOSTON, April 02, 2019 (GLOBE NEWSWIRE) -- resTORbio, Inc. (Nasdaq: TORC), a clinical-stage biopharmaceutical company developing innovative medicines that target the biology of aging to prevent or...
-
Washington, DC, April 02, 2019 (GLOBE NEWSWIRE) -- RALIANCE, a national partnership dedicated to ending sexual violence in one generation, announced today ten recipients of grants totaling $470,000...